Recent evidence suggests that specific extracellular ␣-synuclein (␣-syn) strains are implicated in the progression of Parkinson's disease (PD) pathology. It is plausible that deregulation in the normal processing of secreted ␣-syn may be a causative risk factor for PD. To date, the degradation mechanisms involved have received very little attention. Here, we sought to investigate factors that regulate extracellular ␣-syn levels. We show, for the first time, that cellsecreted ␣-syn forms are resistant to direct proteolysis by kallikrein-related peptidase 6 (KLK6), an extracellular enzyme known to cleave recombinant ␣-syn. This differential susceptibility appears to be partially due to the association of secreted ␣-syn with lipids. We further provide evidence that secreted ␣-syn can be cleaved by KLK6 indirectly through activation of a secreted metalloprotease, suggestive of the involvement of a proteolytic cascade in the catabolism of secreted ␣-syn. Our results clearly suggest that physiological modifications affect the biochemical behavior of secreted ␣-syn and provide novel insights into mechanisms and potential targets for therapeutic interventions.-Ximerakis, M., Pampalakis, G., Roumeliotis, T. I., Sykioti, V.-S., Garbis, S. D., Stefanis, L., Sotiropoulou, G., Vekrellis, K. Resistance of naturally secreted ␣-synuclein to proteolysis. FASEB J. 28, 000 -000 (2014). www.fasebj.org
A plethora of genetic and biochemical evidence supports the notion that ␣-synuclein (␣-syn) plays a central role in the pathogenesis of Parkinson's disease (PD) and other neurodegenerative conditions collectively termed synucleinopathies (1) . It has been demonstrated that various species of ␣-syn, when applied extracellularly, induce multiple neurotoxic (2, 3) and inflammatory responses (4, 5) , and aid the transmission of pathology between neurons (6, 7) .
In this capacity, elucidation of the underlying mechanisms that regulate the protein-levels of extracellular ␣-syn becomes essential. Such mechanisms could involve its proteolytic clearance from the extracellular milieu. To date, in vitro proteolysis studies have implicated certain matrix metalloproteinases (MMPs; refs. 8, 9) , kallikrein-related peptidase 6 (KLK6; refs. 10 -13) , and plasmin (14) in the degradation of extracellular ␣-syn. Among these enzymes, KLK6 has gained much attention, as it was demonstrated to colocalize with ␣-syn in Lewy bodies (LBs; ref. 15) and to catalyze the limited proteolysis of ␣-syn (10) . Furthermore, lentiviral-mediated mouse Klk6 transduction led to inverse changes in pathology in an ␣-syn transgenic mouse model, while its expression was inversely correlated with ␣-syn accumulation in brains with dementia with LBs (DLB; ref. 13) .
KLK6 is a serine protease that is predominantly expressed in the CNS (16) , and has been detected at high levels in human CSF (17) . It is synthesized as a prepropeptide and is activated extracellularly by specific proteolytic release of its propeptide (18) . Recent evidence suggests that its activation may occur in vivo by other proteases, such as kallikrein-related peptidase 5 (KLK5) or plasmin (19) and possibly, to a lesser degree, through autoactivation (20) . The enzymatic activity of KLK6 is ceased by autolysis (20) .
To date, it has not been demonstrated whether physiologically secreted ␣-syn can be catabolized by this protease. In the current study, we aimed to investigate whether KLK6 regulates the steady-state protein levels of naturally secreted ␣-syn under physiologically relevant conditions.
Here, we show that, unlike recombinant forms, the secreted forms of both wild-type (WT) and A53T ␣-syn are resistant to direct KLK6-proteolysis, and this differential susceptibility is partially due to the association of secreted ␣-syn with lipids. Notably, we observed that secreted ␣-syn is processed by KLK6 indirectly and requires the activation of a metalloprotease. These observations raise new questions regarding the properties and fate of naturally secreted ␣-syn, and provide supporting evidence that secreted ␣-syn has specific biochemical characteristics that could impact not only on its structural but also on its functional properties.
MATERIALS AND METHODS

Reagents
All reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA). Recombinant human ␣-syn forms were provided by H. Lashuel (Swiss Federal Institute of Technology, Lausanne, Switzerland). Recombinant human ␤-synuclein (␤-syn) was from rPeptide (Bogart, GA, USA). We used two recombinant mutant forms of human pro-KLK6 (20) . The R80Q mutant (active form) is stable and not subject to autolysis, while the active site S197A mutant (inactive form) is dominantly inactive. The inhibitors of MMP2 (Inhibitor-III; 444288) and MMP9 (Inhibitor-I; 444278) were from Merck Millipore (Billerica, MA, USA). The inhibitor of A disintegrin and metalloproteinase 10 (ADAM10; GI254023X) was kindly provided by A. Ludwig (Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen Germany). RPMI 1640 and Opti-MEM I culture media were from Invitrogen Life Technologies (Carlsbad, CA, USA).
Cell culture
The generation of stable SH-SY5Y cell lines inducibly overexpressing human WT or the A53T ␣-syn has been described previously (21) . ␣-Syn expression was switched off by addition of 1 g/ml doxycycline (doxϩ). Naive SH-SY5Y cells were grown in RPMI supplemented with 10% FBS.
Preparation of conditioned medium (CM) and cell lysate (CL)
The growth medium from 70% confluent ␣-syn-overexpressing SH-SY5Y cells was replaced with serum-free Opti-MEM I for 16 -24 h. This CM was collected, centrifuged to remove floating cells and cell debris, and stored at Ϫ80°C until processed. For immunoblotting, the CM was concentrated by ultrafiltration using 3 kD cutoff Amicon-Ultra filters (Merck Millipore). Cell lysis was in STET lysis buffer (150 mM NaCl; 50 mM Tris, pH 7.6; 2 mM EDTA, pH 8.0; and 1% Triton X-100) supplemented with 1ϫ complete protease inhibitors (Roche, Basel, Switzerland). Protein content was estimated using the Bradford method (Bio-Rad, Hercules, CA, USA).
Metabolic [ 35 S]-labeling of ␣-syn
Cells were starved from methionine and cysteine for 15 min. Assaying proteolysis of secreted ␣-syn CM containing secreted ␣-syn was incubated with various concentrations of recombinant KLK6 forms at 37°C and for various time intervals. Protein levels of ␣-syn were determined either by IP with the Syn-1 antibody and gel autoradiography or by immunoblotting. Protease inhibition assays were conducted by adding inhibitors at concentrations known to cause maximal inhibition (22) .
Assaying proteolysis of IP-purified [ 35 S]-labeled secreted ␣-syn
Immunoprecipitated ␣-syn from the CM was incubated with various concentrations of recombinant KLK6 forms in a reaction buffer (20 mM Tris-HCl, pH 7.6, and 1 mM EDTA, pH 8.0) at 37°C. After 4 h, the reaction mix (supernatant) was collected, and ␣-syn was eluted from the agarose beads. Protein levels were assessed in the IP eluates by gel autoradiography. The presence of KLK6 in the samples was verified by immunoblotting.
Assaying proteolysis of recombinant ␣-syn
Recombinant ␣-syn forms were incubated with recombinant KLK6 forms in a reaction buffer (20 mM Tris-HCl, pH 7.6, and 1 mM EDTA, pH 8.0) at 37°C in varying molar ratios and for various time intervals. The reactions were terminated by addition of sample buffer, and the samples were subjected to electrophoresis. Proteolytic fragments were detected either by overnight staining of the gel with colloidal Coomassie G-250 stain (Invitrogen) or by immunoblotting. Alternatively, recombinant ␣-syn was added in Opti-MEM I or in CM of naive SH-SY5Y cells and then used in proteolytic assays.
Assaying proteolysis of IP-purified recombinant ␣-syn
For control IP experiments, recombinant ␣-syn was added in Opti-MEM I supplemented with 1% BSA to a final concentration of 1 nM (approximately equal to the secreted form). ␣-Syn levels were determined by immunoblotting.
Plasmids and transfection
The generation of the pcDNA3.1(ϩ)/prepro-KLK6 construct has been described previously (23) . The generation of pcDNA3.1(ϩ)/ prepro-KLK6 (S197A) was performed with a 2-step PCR procedure with external and internal primers (external: forward GGAG-GAATTCAGCAGGAGCGGCCATG, reverse TGTCTCGAGT-CAGGGTCACTTGGCCTG; internal: forward GATGCTGGGG-GTCCGCTGGTATGTGGAGACCACCTCCG, reverse ACCAGCG-GACCCCCAGCATCACCCTGGCAGGA). The control plasmid pcDNA3.1(ϩ)/EGFP was provided by Z. Lygerou (University of Patras, Patras, Greece). SH-SY5Y cells were nucleofected using the Amaxa nucleofector (Lonza, Basel, Switzerland).
SDS-PAGE and immunoblotting
Denaturing gel electrophoresis was performed on 13% SDS-PAGE Tris-glycine gels or on 4 -12% NuPAGE Bis-Tris gradient gels (Invitrogen). Proteins were transferred onto nitrocellulose or PVDF membranes (Merck Millipore) and analyzed by immunoblotting. The following antibodies were used: anti-␣-syn, Syn-1 (BD Transduction Laboratories); anti-␣-syn, (C-20)-R (Santa Cruz Biotechnology); anti-␣/␤-syn, N-19 (Santa Cruz Biotechnology); anti-␤-syn, 612508 (BD Transduction Laboratories); anti-BSA, 0220 -1259 (AbD Serotec, Kidlington, UK); anti-Erk2, C-14 (Santa Cruz Biotechnology); anti-DJ-1, KAM-SA100 (Stressgen, San Diego, CA, USA); anti-NOS2, C-11 (Santa Cruz Biotechnology); anti-KLK6 IgY has been described previously (24) . Secondary antibodies (HRP conjugated) were obtained from Jackson ImmunoResearch (West Grove, PA, USA). All immunoblots represent one of Ն3 independent experiments.
Native-PAGE
Blue Native-PAGE was performed on 4 -16% NativePage Novex Bis-Tris gels (Invitrogen). Proteins were transferred onto PVDF membranes using a native buffer (25 mM Trisbase, 25 mM glycine, pH 9.2). NativeMark protein standards (Invitrogen) were used.
Zymography
CM was concentrated by ultrafiltration using the 10 kD cutoff Amicon-Ultra filters (Merck Millipore) and was resolved on 12% SDS-PAGE containing 0.1% gelatin without mercaptoethanol. Gels were incubated at 37°C overnight in 50 mM Tris-HCl (pH 7.5), 5 mM CaCl 2 , and 0.1% Triton X-100 to allow cleavage of gelatin, and then stained with Amido Black.
Enzyme kinetics
The activity of recombinant pro-KLK6 (R80Q) was measured using the synthetic substrate N-benzoyl-l-arginine ethyl ester (BAEE) in 67 mM Na 2 HPO 4 , pH 7.6 (20) , or in other buffers as indicated. The rates of hydrolysis were measured based on changes in the absorbance at 254 nm monitored for 3 min.
Protein crosslinking
The homobifunctional crosslinkers DTBP, DSG, and BS3 (Thermo Scientific, Waltham, MA, USA) were used for the chemical in cell crosslinking assays as described previously (25) . For crosslinking of the secretome (in vitro), CM was first concentrated and then incubated with the crosslinkers.
Protein delipidation
CM was concentrated by ultrafiltration and extracted with chloroform/methanol to remove lipids (26) . Delipidated proteins were lyophilized and stored at Ϫ20°C before further use.
Protein lipidation
Recombinant N-terminally-acetylated ␣-syn was lipidated either by incubation for 24 h at 37°C with fatty acids (F7050, Sigma-Aldrich) diluted (1:80 v/v) in the reaction buffer, or by incubation with phospholipids (B1502, Sigma-Aldrich; stock solution: 20 mg/ml in ethanol) diluted in the reaction buffer to a mass ratio of 1:80.
Proteomics
In-gel dimethyl labeling of ␣-syn cleavage products and digestion
Bands were destained with 50% acetonitrile and 25 mM NH 4 HCO 3 . A 100 l volume of 100 mM triethylammonium bicarbonate and 4 l of 4% CH 2 O was added, followed by addition of 4 l of 0.6M NaBH 3 CN and 1 h incubation (27) . Bands were washed sequentially with 500 l acetonitrile and 500 l destaining solution. Glu-C solution 10 ng/l in 25mM NH 4 HCO 3 was added for overnight digestion, and peptides were extracted with 1% formic acid solution.
Purification and in-solution digestion of ␣-syn IP eluates
The trichloroacetic acid precipitation purification followed by protein reduction and alkylation has been described previously (28) . Glu-C solution (200 ng/l) was added for overnight incubation.
LC-MS analysis
Experiments were performed on the Orbitrap-Elite mass spectrometer (Thermo Scientific) as described previously (28) . The collision-induced dissociation (CID) mass spectra were submitted to Mascot node on the Proteome Discoverer v.1.4 (Thermo Scientific) and included the following parameters: Precursor and Fragment Mass Tolerances 10 ppm and 0.02 Da for the FT-MS or 0.5 Da for the IT-MS spectra. For the dimethyl experiments, spectra were searched for semispecific Glu-C peptides with dimethylated K and N terminus, while for the posttranslational modification (PTM) analysis, spectra were searched for acetylated K, protein N terminus, phosphorylation of S, T, and Y, and oxidation of M. Peptide confidence was fixed with Mascot Percolator at 1% FDR.
RESULTS
KLK6 cleaves recombinant ␣-syn at its N-terminal and core regions
To evaluate the effects of KLK6 on ␣-syn processing, we initially performed proteolytic assays with recombinant ␣-syn. Recombinant human ␣-syn was incubated with enzymatically active (R80Q) or inactive (S197A) recombinant human KLK6, and samples were analyzed by immunoblotting. As shown in Fig. 1A , we found that active KLK6 readily cleaves recombinant ␣-syn at its N terminus, producing proteolytic fragments between 10 and 15 kD. This proteolytic cleavage occurs in a doseand time-dependent manner (Supplemental Fig. S1 ). Since all the PD-associated ␣-syn mutations have been located at the N terminus, we further investigated whether the mutant A53T form of ␣-syn could also be cleaved by KLK6. Under the same conditions, recombinant A53T ␣-syn was also readily cleaved by KLK6 (Fig. 1B) . Interestingly, ␤-syn, which shares a high KLK6 cleavage sites K10, K12, K32, K34, K43, K45, K58, G67, G68, A69, K80, K96, K97 Figure 1 . KLK6 readily cleaves recombinant ␣-syn. A) Recombinant ␣-syn (100 nM) was incubated with 25 nM active (R80Q) or inactive (S197A) KLK6 for 24 h at 37°C. Samples were subjected to gradient gel electrophoresis and analyzed by immunoblotting using specific antibodies to the N terminus (N-19), the core domain (Syn-1), or the C-terminus [(C-20)-R] of ␣-syn. Boiling of KLK6 forms (95°C for 15 min) served as additional control. B, C) Recombinant A53T ␣-syn (100 nM; B), or ␤-syn (C), was incubated with 25 nM active (R80Q) KLK6 for 24 h at 37°C. Samples were analyzed as above, also using a specific antibody for ␤-syn (612508). D) Recombinant ␣-syn, 〈53⌻ ␣-syn, or ␤-syn (6 M) was incubated with the indicated concentrations of the active (R80Q) KLK6 for 24 h at 37°C. Samples were subjected to gradient gel electrophoresis and stained with colloidal Coomassie. Arrows indicate KLK6 protein bands; bracket indicates the generated proteolytic fragments. E) Schematic representation of ␣-syn. Dashed rectangles indicate the core consensus sequence KTKEGV of the 7 imperfect 11-residue repeats with an apolipoprotein lipid-binding motif, while the central red region illustrate the internal hydrophobic domain of the protein. Arrows indicate the KLK6 cleavage sites inferred from N-terminal dimethylation; arrowheads indicate the KLK6 cleavage sites inferred from peptide with non-Glu-C C terminus. All cleavage sites are marked in red.
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degree of amino acid homology with ␣-syn at the N-terminal region, was also readily cleaved by KLK6 (Fig. 1C) .
The cleavage patterns of KLK6 on recombinant ␣-syn forms were further analyzed by Coomassie blue staining (Fig. 1D ). This analysis revealed the formation of additional shorter (Ͻ10 kD) peptide fragments that were not detected by immunoblotting. To characterize these fragments and to investigate the KLK6 cleavage sites within the ␣-syn sequence, we performed LC-MS analysis. This approach revealed that KLK6-proteolysis occurs throughout the N-terminal and core regions of WT recombinant ␣-syn and mostly after lysine residues within the KTKEGV consensus sequence (Fig. 1E and Supplemental Fig. S2 ).
KLK6 cleaves secreted ␣-syn indirectly through activation of a metalloprotease
To examine the proteolysis of secreted ␣-syn, we used CM from SH-SY5Y cells inducibly overexpressing human WT ␣-syn as a source of extracellular ␣-syn.
RT-PCR analysis revealed that these cells do not express endogenous KLK6 (data not shown). Since KLK6 activity is inhibited by serum, we cultured cells in serum-free Opti-MEM I to ensure its proteolytic activity and cell viability in reduced serum conditions. Using our inhouse ELISA (29) we determined the concentration of secreted ␣-syn in this CM to be between 0.5 and 1 nM.
To examine whether secreted ␣-syn is cleaved by KLK6, cells were metabolically labeled with 35 S, and the resultant CM containing 35 S-labeled secreted ␣-syn ( Fig. 2A) was incubated with the active or inactive KLK6. As shown in Fig. 2B , incubation with the active KLK6 resulted in a marked decrease of secreted 35 Slabeled ␣-syn and the appearance of proteolytic fragments. As expected, this proteolysis was blocked by the presence of the serine protease inhibitor aprotinin. Surprisingly, the cleavage of secreted ␣-syn was also inhibited by EDTA, a broad metalloprotease inhibitor, while it was not affected by inhibitors of other protease classes, such as epoxomicin, leupeptin, or pepstatin A (Fig. 2B) . The processing of secreted ␣-syn by KLK6 occurs in a dose-and time-dependent manner (Supplemental Fig. S3 ). Secreted A53T ␣-syn demonstrated the same proteolytic behavior as the WT ␣-syn (Fig. 2C) .
To demonstrate that KLK6 was active in our CM, we used gelatin zymography. As shown in Fig. 2D , zymograms confirmed activity of KLK6 and revealed that both pro-MMP9 and pro-MMP2 were present in the CM of SH-SY5Y cells, as previously reported (30) . Interestingly, the presence of active KLK6 in the CM yielded an additional activity just below the pro-MMP2 band, while incubation of CM with KLK6 in the presence of EDTA inhibited the appearance of this band, implying that this activity most likely corresponds to a secreted metalloprotease.
To exclude the possibility of nonspecific effects of metalloprotease inhibitors on KLK6, we performed enzymatic kinetic assays. As shown in Supplemental Fig.   S4 ,
the proteolytic processing of recombinant ␣-syn by active KLK6 in the absence or presence of metalloprotease inhibitors. As shown in Fig. 3 , EDTA or 1,10-phenanthroline (another broad-spectrum metalloprotease inhibitor) did not block the cleavage of exogenously added recombinant ␣-syn in the unconditioned medium and the CM of naive SH-SY5Y cells, suggesting direct cleavage of recombinant ␣-syn by KLK6.
To further characterize the metalloprotease involved in secreted ␣-syn cleavage in our system, we tested additional potent metalloprotease inhibitors. In line with our previous results, we found that the processing of secreted ␣-syn was completely blocked in the presence of EDTA, 1,10-phenanthroline, marimastat, and EGTA (Supplemental Fig. S5 ). These results suggest that the as yet unidentified secreted metalloprotease requires both zinc (due to its inhibition by EDTA and 1,10-phenanthroline) and calcium (due to its inhibition by EDTA and EGTA) ions as cofactors for its activity and is possibly an MMP or an ADAM metalloprotease (based on its inhibition by marimastat). Considering that MMP2 and MMP9 are expressed and secreted in our cellular model (30) , and that KLK6 was recently shown to activate ADAM10, resulting in Ecadherin shedding (31), we asked whether these proteases were also involved in the proteolysis of secreted ␣-syn. However, selective inhibitors to MMP2, MMP9, or ADAM10 did not affect the processing of secreted ␣-syn by KLK6 even at high concentrations (Supplemental Fig. S3A and Fig. S5B ).
Secreted ␣-syn is resistant to direct proteolysis by KLK6
To validate that another protease is required for KLK6-dependent proteolysis of secreted ␣-syn, we examined whether KLK6 could cleave secreted ␣-syn directly. For this purpose, IP-purified 35 S-labeled secreted ␣-syn was incubated with increasing concentrations of active KLK6. As shown in Fig. 4A-C, KLK6 did not affect the levels of IP-purified secreted ␣-syn. To eliminate the possibility that KLK6 was unable to interact with the IPpurified ␣-syn, we performed identical experiments using recombinant ␣-syn. As shown in Supplemental  Fig. S6 , KLK6 readily cleaved recombinant ␣-syn, at enzyme to substrate molar ratios lower than those used for secreted ␣-syn, thus verifying that in our experimental conditions, KLK6 was able to interact with its substrate. Taken together, these data clearly demonstrate that secreted ␣-syn is resistant to direct KLK6-proteolysis, and additional proteolytic activities are required for its catabolism.
Secreted KLK6 is not autoactivated
To evaluate whether cell-secreted KLK6 could cleave secreted ␣-syn we ectopically expressed KLK6 (WT or S197A mutant), or control EGFP in ␣-syn-overexpressing SH-SY5Y cells. Cells were 35 S-labeled, and their CL and CM were examined for ␣-syn levels by IP and gel autoradiography. Neither intracellular nor extracellular levels of ␣-syn were affected by KLK6 expression (Supplemental Fig. S7 ). Similar results were obtained when CM from 35 S-labeled ␣-syn-overexpressing SH-SY5Y cells was mixed with CM from KLK6-transfected SH-SY5Y cells (data not shown). Although CM from KLK6-transfected cells was found to contain abundant secreted KLK6 (Supplemental Fig. S8 ), we did not detect any activity by gelatin zymography (data not shown), indicating that it is present in its inactive form. These findings imply that the ectopically secreted KLK6 by SH-SY5Y cells or by HEK-293T cells (our own observations) was not autocatalytically activated. Collectively, our data suggest that the processing of secreted ␣-syn may depend on a proteolytic cascade, where at least both KLK6 and an unidentified secreted metalloprotease need to be activated (Fig. 4D) .
Proteolytic resistance of secreted ␣-syn is independent of certain PTMs
To investigate the nature of the observed proteolytic resistance, we first compared the secreted and recombinant ␣-syn forms (WT or A53T) under native conditions. As shown in Fig. 5A , we observed a clear difference in (residues 91-99) . B, C) CM from WT ␣-syn (B) or A53T ␣-syn-overexpressing SH-SY5Y cells (dox Ϫ ; C), were 35 S-labeled and then incubated at 37°C with 50 nM active (R80Q) or inactive (S197A) KLK6 in the presence or absence of various protease inhibitors. After 24 h, CM was analyzed for ␣-syn levels by IP and gel autoradiography. IP with the NOS2 antibody was used as negative control. Arrows indicate intact ␣-syn. Protease inhibitors used: 1ϫ protease inhibitors cocktail EDTA-free (COC); EDTA (10 mM); aprotinin (APR; 10 M); epoxomicin (EPO; 10M); leupeptin (LEU; 100 M); pepstatin-A (PEP; 10 M). D) CM (1.5 ml) from ␣-syn-overexpressing SH-SY5Y cells (dox Ϫ ) was incubated with 50 nM active (R80Q) or inactive (S197A) KLK6 at 37°C in the presence or absence of EDTA. After 15 min, CM was analyzed for enzymatic activity by gelatin zymography. Arrowheads indicate an activated metalloprotease; asterisks indicate nonspecific bands. their electrophoretic mobility. This difference was not induced by other proteins present in CM, since recombinant ␣-syn when added in CM of naive SH-SY5Y cells exhibited the same mobility (Fig. 5B) . The differential electrophoretic mobility between secreted and recombinant ␣-syn forms could be attributed to PTMs. In addition, such modifications could potentially account for its resistance to cleavage. To investigate these possibilities, we first immunoprecipitated the secreted ␣-syn from the CM of ␣-syn-overexpressing SH-SY5Y cells, followed by LC-MS analysis. The only PTM identified in secreted ␣-syn was N-terminal acetylation (confidence Ͼ99%; Supplemental  Fig. S9 ). However, it is possible that other PTMs also occur but cannot be detected due to their low abundance, especially at the C terminus of the protein, where the peptide coverage is limited.
Considering that KLK6 can cleave ␣-syn at the N terminus ( Fig. 1) , we inquired whether the N-terminal acetylation might account for the observed proteolytic resistance of naturally secreted ␣-syn. We found that KLK6 cleaves the recombinant N-terminally acetylated ␣-syn to the same extent as the non-modified form (Supplemental Fig. S10A ). Subsequent experiments also revealed that under native conditions, both the nonmodified and the N-terminally acetylated recombinant ␣-syn exhibited similar, albeit not identical, electrophoretic mobilities, but distinctly different from that of secreted ␣-syn (Supplemental Fig. S10B ). These observations indicate that the differential proteolytic susceptibility of secreted ␣-syn, as well as its distinct electrophoretic mobility, cannot be attributed to its N-terminal acetylation.
Naturally secreted ␣-syn occurs physiologically as a monomer
The differential electrophoretic mobility between recombinant and secreted ␣-syn forms might also be explained by differences in their conformation (32, 33) . Given that such structural differences could also affect the susceptibility of these proteins to proteolysis, we sought to examine the possibility of secreted ␣-syn occurring in a folded conformation. We performed protein crosslinking assays in both ␣-syn-overexpressing SH-SY5Y cells and their CM. As shown in Supplemental Fig. S11A -C, we observed various SDS-resistant oligomers of ␣-syn in the presence of the crosslinkers compared to the controls. Interestingly, we noticed that all three crosslinkers revealed a similar oligomeric pattern for ␣-syn in the CM. To further explore the nature of these ␣-syn oligomeric species in the CM, we performed similar crosslinking assays using recombinant N-terminally acetylated ␣-syn. As shown in Supplemental Fig.  S11D , we found that the oligomeric species revealed were indistinguishable from those present in the crosslinked CM for secreted ␣-syn. If one assumes that recombinant a-syn is monomeric, our data suggest that secreted ␣-syn exists predominantly as a monomer.
Physiological modifications of secreted ␣-syn confer proteolytic resistance
Considering that ␣-syn is a highly thermostable protein (34), we investigated whether KLK6 can cleave denatured secreted ␣-syn. KLK6 readily cleaved boiled secreted ␣-syn even in the presence of EDTA (Fig. 6A) . This proteolysis was independent of secreted metalloproteases, since boiling results in their inactivation. Our data demonstrate that the observed resistance of secreted ␣-syn to KLK6-proteolysis is reversed on heat denaturation, implying that either its conformation in the CM, or perhaps its association with other molecules, could restrict accessibility of the processing enzyme.
To this end, we examined whether heat denaturation of secreted ␣-syn could also affect its electrophoretic mobility. Boiled secreted ␣-syn exhibits a clearly differ- ent electrophoretic mobility to that of nonmodified secreted ␣-syn, but surprisingly identical to that of cytosolic (intracellular) ␣-syn (Fig. 6B) . This difference might be also attributed to the acquisition of distinct conformations, possibly due to differences in the intra/ extracellular environment. Notably, boiling of both cytosolic and recombinant ␣-syns did not alter their electrophoretic mobilities, arguing against the presence of a folded thermally unstable tetramer (Supplemental Fig. S12 ). Collectively, these observations imply that secreted ␣-syn has unique biochemical properties that are different from those of intracellular and recombinant forms.
We next examined whether secreted ␣-syn could be associated with lipids. Such associations may not only alter its structure but also mask its antigenic and cleavage sites. We tested whether delipidation of secreted ␣-syn could alter its electrophoretic mobility under native conditions. As shown in Fig. 6B , the delipidated secreted ␣-syn exhibited similar electrophoretic mobility with that of boiled secreted ␣-syn. These trends suggest that the naturally secreted ␣-syn moiety IP eluates Figure 4 . Secreted ␣-syn is resistant to direct proteolysis by KLK6. CM (2 ml) from 35 S-labeled ␣-syn-overexpressing SH-SY5Y cells (dox Ϫ ) was collected and immunoprecipitated with the Syn-1 antibody. Before elution, the IP-purified secreted 35 S-labeled ␣-syn was incubated for 4 h at 37°C with the indicated concentrations of active (R80Q) or inactive (S197A) KLK6. A, B) IP eluates (A) and a part of the reaction mix (supernatant; B) were subjected to SDS-PAGE, and differences in ␣-syn levels, as well as the existence of proteolytic fragments, were assessed by gel autoradiography. Arrows indicate intact ␣-syn. IP with the NOS2 antibody was used as negative control. C) Immunobloting verified the presence of KLK6 in the reaction mix. D) Schematic representation of the differential proteolytic processing of recombinant and cell-released ␣-syn forms. The serine protease KLK6 cleaves recombinant ␣-syn (solid green line), but is unable to cleave cell-secreted ␣-syn (solid red line). The catabolism of cell-secreted ␣-syn could be mediated by a proteolytic activation cascade, in which KLK6, on its activation, activates an as yet unidentified secreted metalloprotease, which in turn promotes extracellular ␣-syn proteolysis (dashed green arrows).
is associated with lipids. Therefore, we next examined whether delipidated secreted ␣-syn could be cleaved by KLK6. As shown in Fig. 6C , KLK6 was able to directly cleave the delipidated secreted ␣-syn, albeit at a lower efficiency compared to the cleavage of recombinant ␣-syn. These results suggest that the differential susceptibility of secreted ␣-syn to KLK6-proteolysis may be partially attributed to its noncovalent aggregation with lipids.
To further validate this observation, we checked whether lipidation of recombinant ␣-syn could affect its processing by KLK6. To this end, recombinant N-terminally acetylated ␣-syn was incubated with fatty acids or phospholipids and subsequently was incubated with active or inactive KLK6. As shown in Fig. 7 , lipidation of recombinant ␣-syn rendered the protein resistant to KLK6 proteolysis. Enzymatic kinetic experiments confirmed that neither the fatty acids nor the phospholipids interfered with KLK6 activity (Supplemental Fig.  S13 ). We next compared the nonmodified and lipidated recombinant ␣-syn forms under native conditions. As shown in Supplemental Fig. S14 , the lipidated recombinant ␣-syn forms exhibited distinct electrophoretic mobilities to that of nonmodified recombinant ␣-syn. Overall, these data demonstrate for the first time that the association of ␣-syn with lipids affects its proteolytic susceptibility by altering its biochemical properties (Fig. 4D) .
DISCUSSION
Given that ␣-syn is physiologically secreted, it is feasible that the disruption of its canonical degradation and clearance from the extracellular milieu could contribute to the PD disease process. Here, we provide mechanistic insights pertaining to factors that may affect the susceptibility of naturally secreted ␣-syn to proteolysis in the CNS.
In agreement with previous studies (10 -13), we found that KLK6 readily cleaves both recombinant WT and A53T mutant ␣-syn. Antibody mapping showed that proteolysis of recombinant ␣-syn occurs at its N-terminal region. These findings do not agree with a previous report that showed C-terminal proteolysis of ␣-syn by KLK6 (11) . In that study, LC-MS analysis utilized solely trypsin-digested protein bands to characterize the proteolytic fragments. To increase amino acid coverage we also used the complementary enzyme Glu-C that cleaves after glutamic or aspartic acid residues. Our approach revealed that proteolysis occurs at both the N-terminal and core regions of the protein and almost exclusively at lysine residues inside the KTKEGV consensus sequence of the seven imperfect repeats. Interestingly, these cleavage sites from KLK6 are indistinguishable from those of plasmin, another extracellular serine protease that is expressed in the CNS, and which was recently shown to cleave extracellular ␣-syn (14) .
We observed that unlike recombinant forms, secreted ␣-syn is highly resistant to direct proteolysis by KLK6, even at high nanomolar levels. By employing a series of enzymatic and biochemical approaches we showed that KLK6 mediates secreted ␣-syn cleavage indirectly via a secreted metalloprotease, since this proteolysis was completely inhibited in the presence of EDTA, 1,10-phenanthroline, marimastat and EGTA. We attempted to confirm our results using cellularly expressed KLK6, however this did not result in detectable KLK6 activity in the CM. Our inability to detect the active KLK6 enzyme even in highly concentrated CM implies that its autoactivation capacity is not prominent in cellulo. In this respect, it has been shown that in CSF and in other biological samples from normal donors the proportion of active KLK6 relative to its proform is ϳ1000-fold lower (35) , thus making its detection quite difficult. Our finding is in line with a previous study suggesting that activation of KLK6 may occur in vivo by other serine proteases, like KLK5 or plasmin, and to a lesser degree through autoactivation (19) .
KLK6 is thought to be one of the major ␣-syn degrading enzymes. Most of this evidence stems from experiments where primarily recombinant forms of the protein were used (10 -12) . Increased accumulation of ␣-syn, which was associated with decreased KLK6 expression, was demonstrated in postmortem brain tissue of patients with DLB/PD and in ␣-syn-transgenic mouse models (13) . Lentiviral-driven expression of mouse Klk6 reduced intracellular and neuropil aggregates of ␣-syn and reversed the pathology in WT but not in A53T ␣-syn transgenic mice, suggesting a differential specificity of KLK6 for WT ␣-syn (13). However, the study did not provide evidence that the extracellular pool of ␣-syn was affected, and no data regarding the site of enzymatic action of Klk6. Our results demonstrate that on its expression KLK6 is directed for secretion, as the majority of the protein was found in the CM, while only a minute amount was detected intracellularly. In agreement with Tatebe et al. (12) , we also found that the intracellular levels of ␣-syn were not affected by KLK6.
We reasoned that distinct PTMs and/or conformational properties of secreted ␣-syn might affect its susceptibility to KLK6 cleavage and could account for the observed proteolytic resistance. In support of this, we observed a differential electrophoretic behavior between recombinant and secreted ␣-syn under native conditions. To further explore the nature of this difference, we performed LC-MS analysis that revealed only Figure 6 . Heat denaturation and delipidation of secreted ␣-syn affects its proteolytic resistance and its electrophoretic mobility. A) CM (6 ml) from ␣-syn-overexpressing SH-SY5Y cells (dox Ϫ ) was boiled (95°C for 15 min) and then incubated with 10 nM active (R80Q) KLK6 in the presence or absence of 10 mM EDTA (left panel). Non-boiled CM (right panel) was used as control. After 24 h, CM was analyzed for ␣-syn levels and KLK6 presence. Ponceau S staining was used as loading control. B) CM (7 ml; untreated, boiled or delipidated) and 30 ng of recombinant ␣-syn (intact or boiled) were subjected to Blue-Native electrophoresis and analyzed by immunoblotting using the Syn-1 antibody. CL (30 g) from ␣-syn-overexpressing SH-SY5Y cells (dox Ϫ ) was used for comparison. Arrow indicates intact secreted ␣-syn; arrowhead indicates intact and boiled recombinant ␣-syn; black line indicates intracellular and secreted ␣-syn (boiled and delipidated). Bottom panels depict different exposures of the film. C) CM (3 ml) from ␣-syn-overexpressing SH-SY5Y cells (dox Ϫ ) was first extracted from lipids, and then incubated at 37°C with 10 nM active (R80Q) KLK6 in the presence or absence of 10 mM EDTA. After 24 h, CM was analyzed for ␣-syn levels and KLK6 presence by immunoblotting. BSA and Ponceau S staining were used as loading controls.
N-terminal acetylation in the secreted ␣-syn, a PTM previously described for intracellular ␣-syn (36). However, KLK6 cleaved recombinant N-terminally acetylated ␣-syn to the same extent as the nonmodified recombinant protein, indicating that this modification does not play a role in the proteolytic resistance of secreted ␣-syn. Interestingly, the LC-MS analysis revealed oxidized methionines in residues 1 and 5. Although we cannot rule out whether this modification occurred in cellulo, or during the experimental process, it was recently reported that when these methionines are oxidized intracellular ␣-syn becomes resistant to proteolysis by the proteasome (37) .
To further explore the nature of this proteolytic resistance, we examined whether KLK6 can cleave denatured secreted ␣-syn. Intriguingly, we found that KLK6 readily cleaves boiled secreted ␣-syn and this cleavage was direct and independent of any secreted metalloprotease. Under native conditions, heat-denaturation affected the electrophoretic mobility of secreted ␣-syn but not that of intracellular or recombinant ␣-syn. These results suggest that the proteolytic resistance of secreted ␣-syn could be attributed to conformational changes or association with other molecules.
It was recently demonstrated that ␣-syn may exist normally as a helically folded tetramer that resists aggregation (32, 33) and that the N-terminal acetylation of the protein contributes to this folding (38) . Although these data are still under debate (39, 40) , we hypothesized that such a structural difference could explain the distinct electrophoretic mobility of secreted ␣-syn and could affect its proteolytic behavior. In this regard, crosslinking assays of both cell-secreted and recombinant ␣-syns failed to identify differences in the crosslinking pattern between these forms. Our data clearly suggest that the majority of the cell-secreted ␣-syn exists as a monomer.
We next assumed that other factors, like lipids, could affect the structural properties of the protein thus limiting its accessibility to KLK6. We found that delipidation of the CM affected the electrophoretic mobility of secreted ␣-syn, indicating that, similarly to intracellular ␣-syn, secreted ␣-syn is also associated with lipids (26) that could alter its biochemical properties. In support of this, we found that KLK6 was able to directly Figure 7 . Lipidation of recombinant ␣-syn affects its proteolytic susceptibility. Recombinant N-terminally acetylated ␣-syn (acetyl. ␣-syn; 100 nM) was lipidated by incubation with fatty acids (left panel) or phospholipids (right panel) for 24 h at 37°C. These mixtures (40 l) were incubated with 25 nM active (R80Q) or inactive (S197A) KLK6 for an additional 24 h at 37°C. Samples were subsequently analyzed for ␣-syn levels by immunoblotting. As control, acetylated ␣-syn that was not pretreated with fatty acids or phospholipids was used.
cleave delipidated secreted ␣-syn. The absence of lipidation motifs in our LC-MS data is suggestive of noncovalent lipid binding. To further validate our results, we lipidated recombinant ␣-syn using fatty acids and phospholipids and examined how its KLK6 proteolysis was affected. We observed that lipidation affected not only the proteolytic processing of the protein but also its electrophoretic mobility. Thus, the lipidation of recombinant ␣-syn rendered it biochemically more similar to secreted ␣-syn. Overall these data highlight the importance of this modification in the proteolytic resistance of ␣-syn described here.
The resistance of naturally secreted ␣-syn to KLK6 proteolysis is of high importance. There are several reports highlighting the significance of the N-terminal domain (the target region of KLK6) in ␣-syn pathophysiology, since this region appears to be critical for its association with both phospholipids (41) and fatty acids (26) and its concomitant oligomerization (42) . Moreover, recent studies demonstrated that an intact N terminus of recombinant ␣-syn is critical for the formation and structural organization of distinct oligomeric strains responsible for seeding of endogenous ␣-syn (7, 43) .
The differential processing of recombinant vs. secreted ␣-syn, along with their distinct electrophoretic behavior under native conditions, provide evidence that naturally secreted ␣-syn forms might have distinct structural properties that could also impact their functional properties. Hence, caution should be given when interpreting results derived solely from the study of "naked" recombinant ␣-syn. These novel findings supplement our knowledge on the regulation of extracellular ␣-syn and may help to further elucidate its contribution to the pathogenesis of PD.
